Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, mul... von Cognetti, F., Ruggeri, E.M., Felici, A., Gallucci, M., Muto, G., Pollera, C.F., Massidda, B., Rubagotti, A., Giannarelli, D., Boccardo, F., Cantiani, R., Aglietta, M., Bertetto, O., Cetto, G.L., Orlandini, P., Ferrazzi, E., Nardi, M., della Sofferenza, Sollievo, Manzione, L., Adamo, V., Porcile, G., Lentini, M., Breda, E., Gamucci, T., Tummarello, D., Dogliotti, L., Tumolo, S., Motta, M., Lo Russo, V., De Grande, G., Sacco, C., Gaion, F., Lavarello, A., Nuzzo, A., Clerico, M., Aragona, C., Gernone, A., Morelli, F., Olivito, V., Cupini, Mattioli, R., Marra, A., Antimi, M., Silingardi, V., Labianca, R., Martoni, A., Bortolussi, V., Luoni, M., Rosabian, A., Di Vito, F., Catalano, G., Gebbia, N.

Volltext

483P - Designer Peptide Antagonist of the Leptin Receptor with Peripheral Antineoplastic Activity von Beccari, S., Otvos, L.J., Cetto, G.L., Surmacz, E.

Volltext

Designer Peptide Antagonist of the Leptin Receptor with Peripheral Antineoplastic Activity von Beccari, S., Otvos, L.J., Cetto, G.L., Surmacz, E.

Volltext

End of life in cancer patients: drugs or words? von Aitini, E., Adami, F., Cetto, G.L.

Volltext

7019 POSTER Long-term outcome of patients with advanced melanoma von Parolin, V, Nortilli, R, Strina, C, Sabbioni, R, Sava, T, Cetto, G.L

Volltext

532 POSTER Relationships between HER2 and the leptin (Ob/ObR) system in breast cancer von Fiorio, E, Auriemma, A, Mercanti, A, Remo, A, Terrasi, M, Molino, A, Bonetti, M.F, Cetto, G.L, Surmacz, E

Volltext

High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted ve... von Pasini, F., de Manzoni, G., Pedrazzani, C., Grandinetti, A., Durante, E., Gabbani, M., Tomezzoli, A., Griso, C., Guglielmi, A., Pelosi, G., Maluta, S., Cetto, G. L., Cordiano, C.

Volltext

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study von Celio, L., Sternberg, C. N., Labianca, R., La Torre, I., Amoroso, V., Barone, C., Pinotti, G., Cascinu, S., Di Costanzo, F., Cetto, G. L., Bajetta, E.

Volltext

A good death for cancer patients: still a dream? von Aitini, E., Cetto, G. L.

Volltext

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial von Paccagnella, Adriano, Favaretto, A., Oniga, F., Barbieri, F., Ceresoli, G., Torri, W., Villa, E., Verusio, C., Cetto, G.L., Santo, A., De Pangher, V., Artioli, F., Cacciani, G.C., Parodi, G., Soresi, F., Ghi, M.G., Morabito, A., Biason, R., Giusto, M., Mosconi, P., Chiarion Sileni, V.

Volltext

Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC) von Santo, A., Genestreti, G., Sava, T., Manno, P., Terzi, A., Molino, A.M., Cetto, G.L.

Volltext

Gemcitabine and Continuous Infusion of 5-Fluorouracil in Locally Advanced and Metastatic Pancreatic Cancer: A Phase I-II Study von OLIANI, C, PADOVANI, M, MANNO, P, BARANA, I, FALCONI, M, BASSI, C, CAVALLINI, G, PEDERZOLI, P, CETTO, G. L

Volltext

HORMONE REFRACTORY METASTATIC PROSTATE CANCER: DOES PSA HALVING TIME DURING DOCETAXEL TREATMENT HAVE A PROGNOSTIC ROLE? von Porcaro, A.B, Sava, T, Merlin, F, Romano, M, Ghimenton, C, Cesaro, G, Cetto, G.L, Comunale, L

Volltext

Use of the ratio of time to progression following first-and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of c... von Bonetti, A., Zaninelli, M., Leone, R., Franceschi, T., Fraccon, A. P., Pasini, F., Sabbioni, R., Cetto, G. L., Sich, D., Brienza, S., Howell, S. B.

Volltext

307 PSA DECLINING TIME (PSAHI) AS A PROGNOSTIC FACTOR IN METASTATIC HORMONE REFRACTORY PROSTATE CANCER (MHRPC) PATIENTS UNDERGOING DOCETAXEL (TAXOTERE) CHEMOTHERAPY von Porcaro, A.B, Sava, T, Romano, M, Ghimenton, C, Zecchini Antoniolli, S, Cetto, G.L, Comunale, L

Volltext

Prognostic significance of estrogen receptors in 405 primary breast cancers : a comparison of immunohistochemical and biochemical methods von MOLINO, A, MICCIOLO, R, BONETTI, A, NORTILLI, R, TOMEZZOLI, A, POLLINI, G. P, MODENA, S, CETTO, G. L, TURAZZA, M, BONETTI, F, PIUBELLO, Q, CORGNATI, A, SPEROTTO, L, RECALDIN, E, SPAGNOLLI, P, MANFRIN, E

Volltext

A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis von Santo, Antonio, Pedersini, R, Pasini, F, Terzi, A, Pari, F, Cartei, G, Sibau, A, Molino, A, Maiorino, A, Panza, N, Oletti, M.V, Maluta, S, Calabrò, F, Cetto, G.L

Volltext

Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study von Lippe, P., Tummarello, D., Monterubbianesi, M. C., Silva, R. R., Giuliodori, L., Mari, D., Santo, A., Pasini, F., Cetto, G. L., Rossi, D., Porfiri, E., Cascinu, S., Cellerino, R.

Volltext

Does bone marrow involvement affect prognosis in small-cell lung cancer? von Pasini, F., Cetto, G. L., Pelosi, G.

Volltext

Comparison of clinical, biological and pathological characteristics in symptomatic vs asymptomatic breast cancers (BC): study of 1969 patients (pts) von Molino, A., Pavarana, M., Micciolo, R., Castiglioni, P., Cetto, G.L.

Volltext